98%
921
2 minutes
20
Policies play a pivotal role in guiding and overseeing laboratory biosafety management. To ensure that laboratory biosafety management is underpinned by scientifically robust and well-founded policies, an analysis and evaluation of existing policies were conducted. The object was to identify their merits and limitations, thereby offering references for future policy development. The qualitative and quantitative analysis were employed to explore 137 central-level policies issued in China as of April 30, 2024. Additionally, based on policy evaluation theory, a PMC index model was established to evaluate 11 representative laboratory biosafety policies. The results showed that: Firstly, these policies, promulgated by 24 distinct departments, spanned three regulatory tiers: laws, regulations, and administrative rules. Secondly, content analysis revealed three primary aspects: (1) management systems, (2) facility, equipment and containment barrier, and (3) operational technical standards. Thirdly, the average PMC index of the 11 policies was 5.05. Specifically, two policies were deemed excellent, eight policies were acceptable and one was inadequate. The low score was mainly attributed to three indicators: policy level, policy timeliness, and policy content. To sum up, laboratory biosafety policies in China were generally rational and comprehensive. However, insufficient collaboration among departments during policy formulation, as well as the need to improve policy continuity were identified. To enhance biosafety laboratory management, four recommendations are proposed: 1. Strengthen communication among different departments; 2.Optimize the policy formulation process; 3. Enhance supervision of biosafety level 1 and 2 (BSL-1/2) laboratories; 4. Harnessing the power of industry associations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342282 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0328923 | PLOS |
Arch Microbiol
September 2025
College of Biological Sciences, China Agricultural University, Beijing, 100193, China.
Klebsiella oxytoca is a N-fixing bacterium whose nif (nitrogen fixation) gene expression is controlled by the two antagonistic regulatory proteins NifA and NifL encoded by the nifLA operon. NifA is a transcriptional activator, while NifL inhibits the transcriptional activity of NifA. In order to develop an improved K.
View Article and Find Full Text PDFJ Extracell Vesicles
September 2025
Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Osteoarthritis (OA), the prevalent debilitating joint disorder, is accelerated by dysregulated intercellular crosstalk, yet the role of fibroblast-like synoviocyte (FLS)-derived extracellular vesicles and particles (EVPs) in disease progression remains to be elucidated. Here, integrative analysis of clinical specimens, animal models, and publicly available datasets revealed significant alterations in exosomal pathways within OA synovium. Proteomic profiling revealed distinct molecular signatures in EVPs derived from inflammatory and senescent FLSs, reflecting the pathophysiological status of their parent cells.
View Article and Find Full Text PDFHepatitis B virus (HBV) precore G1896A mutation is closely associated with poor prognosis of liver disease. We previously revealed that the G1896A mutation could enhance HBV replication and promote hepatocellular carcinoma (HCC) cell growth both in vitro and in vivo. However, the in-depth mechanisms by which this mutation promotes the malignancy of HCC still need to be explored.
View Article and Find Full Text PDFInt J Nanomedicine
September 2025
Department of Ultrasonic Imaging, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Background: Due to the complex structure and variable microenvironment in the progression of bladder cancer, the efficacy of traditional treatment methods such as surgery and chemotherapy is limited. Tumor residual, recurrence and metastasis are still difficult to treat. The integration of diagnosis and treatment based on nanoparticles can offer the potential for precise tumor localization and real-time therapeutic monitoring.
View Article and Find Full Text PDFInt J Nanomedicine
September 2025
Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu, People's Republic of China.
Introduction: Oral squamous cell carcinoma (OSCC) has a poor prognosis due to its immunosuppressive tumor microenvironment (TME), in which tumor-associated macrophages (TAMs) play a pivotal role in promoting disease progression and therapeutic resistance. This study examines whether Prussian blue nanoparticles (PB NPs) could reprogram TAMs and block tumor-stroma communication in OSCC.
Methods: PB NPs were synthesized using polyvinylpyrrolidone-assisted coprecipitation and characterized by transmission electron microscopy, dynamic light scattering, and UV-Vis spectroscopy.